Massachusetts Financial Services’s Cullinan Oncology CGEM Stock Holding History

Massachusetts Financial Services’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$577K	Buy	+31,713	New	+$471K	﹤0.01%	942

Other funds holding CGEM

TFCP

Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Massachusetts Financial Services's CGEM Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 31,713 shares worth $577K. The stake represents ﹤0.01% of the portfolio and ranks #942 among its holdings.

31 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

Massachusetts Financial Services held 31,713 shares of Cullinan Oncology worth $577K as of Q2 2026.
Cullinan Oncology was a new Massachusetts Financial Services position in Q2 2026.
Cullinan Oncology made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #942 holding.
31 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.